Novo Nordisk posted 2025 constant-currency sales growth of 10% and operating profit growth of 6%, in line with guidance,...

Novartis posted full-year 2025 net sales of $54.5 billion, up 8% at constant currency, with core operating income rising...

Beghou has elevated Meredith Ressi to President and Chief Growth Officer, expanding her remit from growth to end-to-end client...

60 Degrees Pharmaceuticals has partnered with GoodRx to offer up to 30% savings on Arakoda (tafenoquine), the once-weekly, FDA‑approved...

CorMedix Therapeutics has authorized a share repurchase program of up to $75 million through December 31, 2027, with purchases...

Harrow reaffirmed its 2025 revenue guidance of $270–280 million and outlined an aggressive commercial ramp across its ophthalmology portfolio....

Breakthru Medicine has emerged from stealth with a $60 million Series A following a prior undisclosed seed round, aiming...

At a featured session during the 2025 BIO-Europe conference, leaders from Abivax and Sofinnova Partners detailed the dramatic transformation...

Mesoblast posted a decisive second fiscal quarter: Ryoncil gross sales reached $35 million with net revenue of $30 million,...